A victory for statins or a defeat for diet policies? Cholesterol falls in Poland in the past decade: A modeling study

International Journal of Cardiology

Volumn 185, Issue , 2015, Pages 313-319

  Bandosz, Piotr ^a,b   O'Flaherty, Martin ^b   Rutkowski, Marcin ^a   Kypridemos, Chris ^b   Guzman Castillo, Maria ^b   Gillespie, Duncan O S ^b   Solnica, Bogdan ^c   Pencina, Michael J ^d   Wyrzykowski, Bogdan ^a   Capewell, Simon ^b   Zdrojewski, Tomasz ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^d DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

Cholesterol; Cross sectional studies; Hydroxymethylglutaryl CoA reductase inhibitors; Nutrition policy

Indexed keywords

ATORVASTATIN; CHOLESTEROL; FENOFIBRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET THERAPY; DRUG EFFICACY; DRUG USE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POLAND; POPULATION RESEARCH; PRIORITY JOURNAL; REFERENCE VALUE; TREATMENT RESPONSE; VENOUS BLOOD; YOUNG ADULT; ADOLESCENT; BLOOD; CARDIOVASCULAR DISEASES; DIET; INCIDENCE; NUTRITIONAL STATUS; PROCEDURES; RISK ASSESSMENT; STANDARDS; THEORETICAL MODEL; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CHOLESTEROL; CROSS-SECTIONAL STUDIES; DIET; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; MALE; MIDDLE AGED; MODELS, THEORETICAL; NUTRITIONAL STATUS; POLAND; RISK ASSESSMENT; YOUNG ADULT;

EID: 84928254978     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.03.079     Document Type: Article

References (46)

1. T. Laatikainen, J. Critchley, E. Vartiainen, V. Salomaa, M. Ketonen, and S. Capewell Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997 Am. J. Epidemiol. 162 8 2005 764 773
2. T. Aspelund, V. Gudnason, B.T. Magnusdottir, K. Andersen, G. Sigurdsson, B. Thorsson, L. Steingrimsdottir, J. Critchley, K. Bennett, M. O'Flaherty, and S. Capewell Analysing the large decline in coronary heart disease mortality in the Icelandic population aged 25-74 between the years 1981 and 2006 PLoS One 5 11 2010 e13957
3. J. Bruthans, R. Cífková, V. Lánská, M. O'Flaherty, J.A. Critchley, J. Holub, P. Jansky, J. Zvárová, and S. Capewell Explaining the decline in coronary heart disease mortality in the Czech Republic between 1985 and 2007 Eur. J. Prev. Cardiol. 21 7 2014 Jul 829 839
4. L. Björck, A. Rosengren, K. Bennett, G. Lappas, and S. Capewell Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002 Eur. Heart J. 30 9 2009 1046 1056
5. P. Bandosz, M. O'Flaherty, W. Drygas, M. Rutkowski, J. Koziarek, B. Wyrzykowski, K. Bennett, T. Zdrojewski, and S. Capewell Decline in mortality from coronary heart disease in Poland after socioeconomic transformation: modelling study BMJ 344 2012 d8136
6. A. Keys Serum cholesterol response to dietary cholesterol Am. J. Clin. Nutr. 40 2 1984 351 359
7. D. Mozaffarian, M.B. Katan, A. Ascherio, M.J. Stampfer, and W.C. Willett Trans fatty acids and cardiovascular disease N. Engl. J. Med. 354 15 2006 1601 1613
8. P. Pietinen, E. Vartiainen, R. Seppänen, A. Aro, and P. Puska Changes in diet in Finland from 1972 to 1992: impact on coronary heart disease risk Prev. Med. 25 3 1996 243 250
9. C.L. Johnson, B.M. Rifkind, C.T. Sempos, M.D. Carroll, P.S. Bachorik, R.R. Briefel, D.J. Gordon, V.L. Burt, C.D. Brown, and K. Lippel Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys JAMA 269 23 1993 3002 3008
10. N.J. Stone, J. Robinson, A.H. Lichtenstein, C.N. Bairey Merz, D.M. Lloyd-Jones, C.B. Blum, P. McBride, R.H. Eckel, J.S. Schwartz, A.C. Goldberg, S.T. Shero, D. Gordon, S.C. Smith, D. Levy, K. Watson, and P.W. Wilson ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J. Am. Coll. Cardiol. 2013 2013
11. B. Thorsson, L. Steingrimsdottir, S. Halldorsdottir, K. Andersen, G. Sigurdsson, T. Aspelund, and V. Gudnason Changes in total cholesterol levels in Western societies are not related to statin, but rather dietary factors: the example of the Icelandic population Eur. Heart J. 34 24 2013 1778 1782
12. M. Eliasson, U. Janlert, J.H. Jansson, and B. Stegmayr Time trends in population cholesterol levels 1986-2004: influence of lipid-lowering drugs, obesity, smoking and educational level. The northern Sweden MONICA study J. Intern. Med. 260 6 2006 551 559
13. L.M. Valsta, H. Tapanainen, J. Sundvall, T. Laatikainen, S. Männistö, P. Pietinen, and E. Vartiainen Explaining the 25-year decline of serum cholesterol by dietary changes and use of lipid-lowering medication in Finland Public Health Nutr. 13 6A 2010 932 938
14. R. Cífková, Z. Skodová, J. Bruthans, V. Adámková, M. Jozífová, M. Galovcová, P. Wohlfahrt, A. Krajcoviechová, R. Poledne, P. Stávek, and V. Lánská Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and Czech post-MONICA Atherosclerosis 211 2 2010 676 681
15. J.D. Cohen, M.J. Cziraky, Q. Cai, A. Wallace, T. Wasser, J.R. Crouse, and T.A. Jacobson 30-year trends in serum lipids among United States adults: results from the National Health and Nutrition Examination Surveys II, III, and 1999-2006 Am. J. Cardiol. 106 7 2010 969 975
16. W.A. Zatonski, A.J. McMichael, and J.W. Powles Ecological study of reasons for sharp decline in mortality from ischaemic heart disease in Poland since 1991 BMJ 316 7137 1998 1047 1051
17. M. Bobak, Z. Skodova, Z. Pisa, R. Poledne, and M. Marmot Political changes and trends in cardiovascular risk factors in the Czech Republic, 1985-92 J. Epidemiol. Community Health 51 3 1997 272 277
18. European health for all database, WHO Regional Office for Europe, Copenhagen, Denmark.
19. T. Zdrojewski, P. Szpakowski, P. Bandosz, A. Pajak, A. Wiecek, B. Krupa-Wojciechowska, and B. Wyrzykowski Arterial hypertension in Poland in 2002 J. Hum. Hypertens. 18 8 2004 557 562
20. T. Zdrojewski, M. Rutkowski, P. Bandosz, Z. Gaciong, T. Jędrzejczyk, B. Solnica, M. Pencina, W. Drygas, B. Wojtyniak, T. Grodzicki, J. Piwoński, and B. Wyrzykowski Prevalence and control of cardiovascular risk factors in Poland. Assumptions and objectives of the NATPOL 2011 Survey Kardiol. Pol. 71 4 2013 381 392
21. S.X. Kong, S.Y. Crawford, S.K. Gandhi, J.D. Seeger, G.T. Schumock, N.P. Lam, J. Stubbings, and M.D. Schoen Efficacy of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in the treatment of patients with hypercholesterolemia: a meta-analysis of clinical trials Clin. Ther. 19 4 1997 778 797
22. J.E. Edwards, and R.A. Moore Statins in hypercholesterolaemia: a dose-specific meta-analysis of lipid changes in randomised, double blind trials BMC Fam. Pract. 4 2003 18
23. P. Jones, S. Kafonek, I. Laurora, and D. Hunninghake Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study) Am. J. Cardiol. 81 5 1998 582 587
24. Poland National Sales Data, IMS Health (personal communication).
25. W.S. Cleveland, E. Grosse, and W.M. Shy Local regression models Hastie JMCaTJ, Statistical Models in S: Hastie 1992 Wadsworth & Brooks/Cole
26. The SAS system for Windows. Release 9.3. SAS Inst., Cary, NC.
27. R Core Team R: A language and environment for statistical computing 2014 R Foundation for Statistical Computing Vienna, Austria URL http://www.R-project.org/
28. W.A. Zatonski, and W. Willett Changes in dietary fat and declining coronary heart disease in Poland: population based study BMJ 331 7510 2005 187 188
29. B. Unal, J.A. Critchley, and S. Capewell Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000 Circulation 109 9 2004 1101 1107
30. A. Aranowska, A. Was̈kiewicz, and D. Szczes̈niewska Zmiany w spożyciu tłuszczów ws̈ród dorosłych mieszkańców Warszawy, w okresie 28 lat. (conference abstract) Conference: Kardiologia Prewencyjna, 2014-11-22. Krakow 2014 47
31. J. Perk, G. De Backer, H. Gohlke, I. Graham, Z. Reiner, M. Verschuren, C. Albus, P. Benlian, G. Boysen, R. Cifkova, C. Deaton, S. Ebrahim, M. Fisher, G. Germano, R. Hobbs, A. Hoes, S. Karadeniz, A. Mezzani, E. Prescott, L. Ryden, M. Scherer, M. Syvänne, W.J. Scholte op Reimer, C. Vrints, D. Wood, J.L. Zamorano, F. Zannad, (EACPR) EAfCPaR, and (CPG) ECfPG European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) Eur. Heart J. 33 13 2012 1635 1701
32. Z. Ahmad Statin intolerance Am. J. Cardiol. 113 10 2014 1765 1771
33. T. Jørgensen, R. Kart Jacobsen, U. Toft, M. Aadahl, C. Glümer, and C. Pisinger The effect of screening and lifestyle counselling on incidence of ischaemic heart disease in a general population: a randomised trial - Inter99 BMJ 348 2014 g3617
34. F. Lloyd-Williams, M. O'Flaherty, M. Mwatsama, C. Birt, R. Ireland, and S. Capewell Estimating the cardiovascular mortality burden attributable to the European Common Agricultural Policy on dietary saturated fats Bull. World Health Organ. 86 7 2008 535 541A
35. P. Scarborough, S. Allender, D. Clarke, K. Wickramasinghe, and M. Rayner Modelling the health impact of environmentally sustainable dietary scenarios in the UK Eur. J. Clin. Nutr. 66 6 2012 710 715
36. M.J. Pencina, A.M. Navar-Boggan, R.B. D'Agostino, K. Williams, B. Neely, A.D. Sniderman, and E.D. Peterson Application of new cholesterol guidelines to a population-based sample N. Engl. J. Med. 370 15 2014 1422 1431
37. S. Capewell, and M. O'Flaherty Rapid mortality falls after risk-factor changes in populations Lancet 378 9793 2011 752 753
38. E. Vartiainen, T. Laatikainen, M. Peltonen, A. Juolevi, S. Männistö, J. Sundvall, P. Jousilahti, V. Salomaa, L. Valsta, and P. Puska Thirty-five-year trends in cardiovascular risk factors in Finland Int. J. Epidemiol. 39 2 2010 504 518
39. M. Franco, U. Bilal, P. Orduñez, M. Benet, A. Morejón, B. Caballero, J.F. Kennelly, and R.S. Cooper Population-wide weight loss and regain in relation to diabetes burden and cardiovascular mortality in Cuba 1980-2010: repeated cross sectional surveys and ecological comparison of secular trends BMJ 346 2013 f1515
40. M. Bajekal, S. Scholes, H. Love, N. Hawkins, M. O'Flaherty, R. Raine, and S. Capewell Analysing recent socioeconomic trends in coronary heart disease mortality in England, 2000-2007: a population modelling study PLoS Med. 9 6 2012 e1001237
41. I. Johansson, L.M. Nilsson, B. Stegmayr, K. Boman, G. Hallmans, and A. Winkvist Associations among 25-year trends in diet, cholesterol and BMI from 140,000 observations in men and women in Northern Sweden Nutr. J. 11 2012 40
42. J. Critchley, J. Liu, D. Zhao, W. Wei, and S. Capewell Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999 Circulation 110 10 2004 1236 1244
43. O. Saidi, N. Ben Mansour, M. O'Flaherty, S. Capewell, J.A. Critchley, and Romdhane H. Ben Analyzing recent coronary heart disease mortality trends in Tunisia between 1997 and 2009 PLoS One 8 5 2013 e63202
44. S. Rastam, R. Al Ali, W. Maziak, F. Mzayek, F.M. Fouad, M. O'Flaherty, and S. Capewell Explaining the increase in coronary heart disease mortality in Syria between 1996 and 2006 BMC Public Health 12 2012 754
45. J. Mindell, J.P. Biddulph, V. Hirani, E. Stamatakis, R. Craig, S. Nunn, and N. Shelton Cohort profile: the health survey for England Int. J. Epidemiol. 41 6 2012 1585 1593
46. Z. Kostrzewa, and D. Szałtys Migracje zagraniczne ludnos̈ci - Narodowy Spis Powszechny 2011 Warszawa: Główny Urząd Statystynczy 2013 Main Statistical Office in Poland